Ureteral Stents Market Size Projected to Reach USD 625.17 million by 2030 at a 5.6% CAGR, Says AMR

January 28, 2025 08:09 AM GMT | By EIN Presswire
 Ureteral Stents Market Size Projected to Reach USD 625.17 million by 2030 at a 5.6% CAGR, Says AMR
Image source: EIN Presswire

The growing incidence of urological and kidney-related disorders and the adoption of technologically advanced stents are the major factors driving the market. PORTLAND, OR, UNITED STATES, January 28, 2025 /EINPresswire.com/ -- Ureteral stent is a thin hollow tube that is inserted into the ureter to alleviate blockages in the kidney's urine flow. These stents are used to treat various urological disorders, such as kidney stones, tumors, and urinary incontinence. These ureteral stents allow remaining fragments to pass through without blocking the ureter. In fact, any urological or kidney-related procedure mostly necessitates the use of a ureteral stent for the ureter to recover properly. The ureteral stent removal takes place after treatment procedure. Furthermore, the high prevalence of prostate cancer, tumors, or ureteral narrowing/scarring necessitates the use of ureteral stents during and after therapy.

Allied Market Research has published a study report with the title Ureteral Stents Market Size was Valued at USD 362.34 million in 2020, and is Projected to Garner USD 625.17 million by 2030, registering a CAGR of 5.6% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐔𝐫𝐞𝐭𝐞𝐫𝐚𝐥 𝐒𝐭𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?

Significant surge in the cases of urological diseases caused by colonization of microorganisms or sedentary lifestyle, growth in the geriatric population, and rise in healthcare investments in developed and developing countries are expected to drive the growth of the global ureteral stents market. On the other hand, lack of skilled professional is expected to hinder the growth to some extent. However, development of ureteral stent tracker products is expected to create ample opportunities for the industry.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/4414

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐨𝐟 𝐔𝐫𝐞𝐭𝐞𝐫𝐚𝐥 𝐒𝐭𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: -

• Boston Scientific Corporation
• B. Braun Holding GmbH & Co. KG
• Cook Group Incorporated
• C. R. Bard, Inc.
• Coloplast Ltd.
• Medline Industries, Inc.
• Allium Medical Solutions Ltd.
• Pnn Medical A/S
• Teleflex Incorporated
• Olympus Corporation.

𝐔𝐫𝐞𝐭𝐞𝐫𝐚𝐥 𝐒𝐭𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: -

The report offers a detailed segmentation on the global ureteral stents market based on product type, material, application, end-user and region.

Based on material, the metallic stents segment held the largest market share in 2020, garnering more than two-thirds of the global market. The polymer stents segment, on the other hand, is expected to cite the fastest CAGR of 7.5% during the forecast period.

Based on application, the urinary continence segment, held the majority market share in 2020, holding more than half of the global ureteral stents market. The kidney stones segment, on the other hand, is predicted to exhibit the fastest CAGR of 7.9% during the forecast period.

Based on region, the market across North America held the lion's share in 2020, garnering more than two-fifths of the global market. The Asia-Pacific region, on the other hand, is predicted to cite the fastest CAGR of 6.3% during the forecast period.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/4414

KEY FINDINGS OF THE STUDY

• By product type, the double pigtail stents segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 5.2% from 2021 to 2030.
• By application, the urinary incontinence segment is projected to grow at a CAGR of 4.9% during the forecast period.
• By material, the metallic stents segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 4.6% from 2021 to 2030.
• By end user, the hospital segment is projected to grow at a CAGR of 6.3% during the forecast period.
• Region-wise, North America is expected to experience growth at the highest rate, registering a CAGR of 5.9% during the forecast period.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
[email protected]

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Market Research
+ +1 800-792-5285
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next